Profil
Scott A. Beardsley is currently the Director at Anthos Therapeutics, Inc. and the Managing Partner at Novo Ventures (US), Inc. He previously worked as a Managing Director at JPMorgan Securities LLC, Managing Director at Piper Jaffray Cos., Independent Director at Inogen, Inc., Independent Director at Aerocrine AB, and Senior Partner at Novo Principal Investments.
Mr. Beardsley has an undergraduate degree from Colorado State University and an MBA from UCLA Anderson School of Management.
Postes actifs de Scott A. Beardsley
| Sociétés | Poste | Début |
|---|---|---|
Novo Ventures (US), Inc.
Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world. | Private Equity Investor | 01/01/2012 |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Scott A. Beardsley
| Sociétés | Poste | Fin |
|---|---|---|
| INOGEN, INC. | Directeur/Membre du Conseil | 12/02/2021 |
| AEROCRINE AB | Directeur/Membre du Conseil | 12/05/2014 |
Piper Jaffray Cos.
Piper Jaffray Cos. Investment Banks/BrokersFinance Provides broker and investment banking services | Corporate Officer/Principal | 01/01/2006 |
Unchained Labs
Unchained Labs BiotechnologyHealth Technology Designs, develops and manufactures tools & devices for biologics and gene therapy research | Directeur/Membre du Conseil | - |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides corporate, investment banking, consumer and commercial banking, asset management, payment & security solutions | Analyst-Equity | - |
Formation de Scott A. Beardsley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides corporate, investment banking, consumer and commercial banking, asset management, payment & security solutions | Finance |
Piper Jaffray Cos.
Piper Jaffray Cos. Investment Banks/BrokersFinance Provides broker and investment banking services | Finance |
Inogen, Inc.
Inogen, Inc. Medical SpecialtiesHealth Technology Operates as a medical technology company | Health Technology |
Aerocrine AB
Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes medical devices for asthma patients | Electronic Technology |
Colorado State University
Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Ventures (US), Inc.
Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world. | Finance |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unchained Labs
Unchained Labs BiotechnologyHealth Technology Designs, develops and manufactures tools & devices for biologics and gene therapy research | Health Technology |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Health Technology |
















